Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Angina IV: Management

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

Lipid Digestion

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Lipidology update : Evidence-based treatment of dyslipidemia].

Der Internist·2020

Same author

MMW Fortschritte der Medizin·2020

Same author

MMW Fortschritte der Medizin·2020

Same author

Impact of perceptions of body size on obesity and weight management behaviour: a large representative population study in an African setting.

Journal of public health (Oxford, England)·2019

Same author

MMW Fortschritte der Medizin·2019

Same author

MMW Fortschritte der Medizin·2019

Search research articles

Related Experiment Video

Updated: May 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Update dyslipidemia].

K G Parhofer¹

¹Medizinische Klinik und Poliklinik II, Klinikum der Universität München, Campus Großhadern, Marchioninistr. 15, 81377, München, Deutschland. klaus.parhofer@med.uni-muenchen.de

|August 10, 2013

Summary

Managing dyslipidemia is key for preventing atherosclerosis. Treatment involves statins for LDL cholesterol, with other lipids and risk factors considered for comprehensive cardiovascular care.

Area of Science:

Cardiovascular Medicine
Metabolic Disorders
Pharmacology

Context:

Dyslipidemia management is crucial for preventing atherosclerosis.
Statins are primary for reducing low-density lipoprotein (LDL) cholesterol.
The role of other lipids (triglycerides, HDL-cholesterol, lipoprotein(a)) is under ongoing discussion.

Purpose:

To outline current strategies for dyslipidemia treatment and atherosclerosis prevention.
To emphasize the importance of individualized LDL cholesterol targets based on patient risk.
To discuss therapeutic options beyond statins for complex hyperlipidemias.

Summary:

Lifestyle modifications are significant for hypertriglyceridemia and combined hyperlipoproteinemia.
Therapeutic strategies should include addressing all cardiovascular risk factors.

Related Experiment Videos

Last Updated: May 9, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Combination therapies (ezetimibe, bile acid binders, fibrates, ω-3 fatty acids) should be considered when statins are insufficient, based on lipid profiles, risk, and side effects.

Lipid apheresis is an option for severe cases with progressive cardiovascular disease.

Impact:

Provides a framework for optimizing dyslipidemia treatment to reduce cardiovascular events.
Highlights the need for a multi-faceted approach to lipid management.
Informs clinical decision-making for complex lipid disorders and high-risk patients.